REFERENCES

• GelbDJ.OliverE.GilmanS.Diagnostic criteria for Parkinson disease.Arch Neurol19995633399923759
   PubMed Web of Science ®Google Scholar
• de RijkMC.LaunerLJ.BergerK.et al.Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.Neurology200054(11 suppl 5)S21S2310854357
   PubMed Web of Science ®Google Scholar
• BowerJH.MaraganoreDM.McDonnellSK.RoccaWA.Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.Neurology1999521214122010214746
   PubMed Web of Science ®Google Scholar
• ElbazA.BowerJH.PetersonBJ.et al.Survival study of Parkinson disease in Olmsted County, Minnesota.Arch Neurol200360919612533094
   PubMedGoogle Scholar
• FallPA.SalehA.FredricksonM.OlssonJE.GranerusAK.Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up.Mov Disord2003181312131614639673
   PubMed Web of Science ®Google Scholar
• HerlofsonK.LieSA.ArslandD.LarsenJP.Mortality and Parkinson disease: a community-based study.Neurology20046293794215037696
   PubMed Web of Science ®Google Scholar
• HornykiewiczO.L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.Amino Acids200223657012373520
   PubMed Web of Science ®Google Scholar
• KatzenschlagerR.LeesAJ.Treatment of Parkinson's disease: levodopa as the first choice.J Neurol2002249(suppl 2)1119112412420716
   PubMedGoogle Scholar
• KostrzewaRM.KostrzewaJP.BrusR.Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.Amino Acids200223576312373519
   PubMed Web of Science ®Google Scholar
• LangstonJW.BallardP.TetrudJW.IrwinI.Chronic parkinsonism in humans due to a product of meperidine-analog synthesis.Science19832199799806823561
   PubMed Web of Science ®Google Scholar
• LangstonJW.LangstonEB.IrwinI.MPTP-induced parkinsonism in human and non-human primates - clinical and experimental aspects.Acta Neurol Scand Suppl198410049546333134
   PubMedGoogle Scholar
• GainetdinovRR.FumagalliF.JonesSR.CaronMG.Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.J Neurochern19976913221325
   PubMed Web of Science ®Google Scholar
• KitayamaS.WangJB.UhlGR.Dopamine transporter mutants selectively enhance MPP+ transport.Synapse19931558628310426
   PubMed Web of Science ®Google Scholar
• AliSF.DavidSN.NewportGD.CadetJL.SlikkerW Jr.MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels.Synapse19941827347825121
   PubMed Web of Science ®Google Scholar
• PaulusW.JellingerK.The neuropathologic basis of different clinical subgroups of Parkinson's disease.J Neuropathol Exp Neurol1991507437551748881
   PubMed Web of Science ®Google Scholar
• GibbWR.LeesAJ.Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.J Neurol Neurosurg Psychiatry1991543883961865199
   PubMed Web of Science ®Google Scholar
• MooreRY.Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease.Parkinsonism Relat Disord20039(suppl 2)S65S7112915070
   PubMed Web of Science ®Google Scholar
• HornykiewiczO.Chemical neuroanatomy of the basal ganglia - normal and in Parkinson's disease.J Chern Neuroanat200122312
   PubMed Web of Science ®Google Scholar
• RibeiroMJ.VidailhetM.Loc'hC.et al.Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease.Arch Neurol20025958058611939892
   PubMedGoogle Scholar
• MarekK.InnisR.van DyckC.et al.[123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.Neurology2001572089209411739831
   PubMed Web of Science ®Google Scholar
• GibbWR.Functional neuropathology in Parkinson's disease.Eur Neurol199738(suppl 2)21259387799
   PubMed Web of Science ®Google Scholar
• JellingerKA.Recent developments in the pathology of Parkinson's disease.J Neural Transm Suppl20026234737612456078
   PubMedGoogle Scholar
• GibbWR.Neuropathology of the substantia nigra.Eur Neurol199131(suppl 1)48591830274
   PubMed Web of Science ®Google Scholar
• McRitchieDA.CartwrightHR.HallidayGM.Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.Exp Neurol19971442022139126172
   PubMed Web of Science ®Google Scholar
• CasparP.StepniewskaI.KaasJH.Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys.J Comp Neurol1992325121 1362430
   PubMed Web of Science ®Google Scholar
• GasparP.DuyckaertsC.AlvarezC.Javoy-AgidF.BergerB.Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease.Ann Neurol1991303653741683212
   PubMed Web of Science ®Google Scholar
• MassonG.MestreD.BlinO.Dopaminergic modulation of visual sensitivity in man.Fundam Clin Pharmacol199374494638294083
   PubMed Web of Science ®Google Scholar
• PriceMJ.FeldmanRG.AdelbergD.KayneH.Abnormalities in color vision and contrast sensitivity in Parkinson's disease.Neurology1992428878901565248
   PubMed Web of Science ®Google Scholar
• HaugBA.TrenkwalderC.ArdenGB.OertelWH.PaulusW.Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease.Mov Disord199495635707990852
   PubMed Web of Science ®Google Scholar
• WinkB.HarrisJ.A model of the Parkinsonian visual system: support for the dark adaptation hypothesis.Vision Res2000401937194610837836
   PubMed Web of Science ®Google Scholar
• Bodis-WollnerI.Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300.Clin Electroencephalogr1997281431479241467
   PubMedGoogle Scholar
• GalzettiS.FranchiA.TaratufoloG.GroppiE.Simultaneous VEP and PERG investigations in early Parkinson's disease.J Neurol Neurosurg Psychiatry1990531141172313297
   PubMed Web of Science ®Google Scholar
• MullerT.KuhnW.ButtnerT.PrzuntekH.Distorted colour discrimination in Parkinson's disease is related to severity of the disease.Acta Neurol Scand1997962932969404998
   PubMed Web of Science ®Google Scholar
• PeppeA.StanzioneP.PierantozziM.et al.Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?Electroencephalogr Clin Neurophysiol19981063743829741766
   PubMedGoogle Scholar
• HarnoisC.Di PaoloT.Decreased dopamine in the retinas of patients with Parkinson's disease.Invest Ophthalmol Vis Sci199031247324752243012
   PubMed Web of Science ®Google Scholar
• HawkesCH.ShephardBC.DanielSE.Olfactory dysfunction in Parkinson's disease.J Neurol Neurosurg Psychiatry1997624364469153598
   PubMed Web of Science ®Google Scholar
• Del TrediciK.RubU.de VosRA.BohlJR.BraakH.Where does parkinson disease pathology begin in the brain?J Neuropathol Exp Neurol20026141342612030260
   PubMed Web of Science ®Google Scholar
• DoubleKL.RoweDB.HayesM.et al.Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test.Arch Neurol20036054554912707068
   PubMed Web of Science ®Google Scholar
• BerendseHW.BooijJ.FrancotCM.et al.Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell.Ann Neurol200150344111456307
   PubMed Web of Science ®Google Scholar
• HuismanE.UylingsHB.HooglandPV.A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.Mov Disord20041968769215197709
   PubMed Web of Science ®Google Scholar
• EnnisM.ZhouFM.CiomborKJ.et al.Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals.J Neurophysiol2001862986299711731555
   PubMed Web of Science ®Google Scholar
• KosterNL.NormanAB.RichtandNM.et al.Olfactory receptor neurons express D2 dopamine receptors.J Comp Neurol199941166667310421875
   PubMed Web of Science ®Google Scholar
• BetarbetR.TurnerR.ChockkanV.et al.Dopaminergic neurons intrinsic to the primate striatum.J Neurosci199717676167689254687
   PubMed Web of Science ®Google Scholar
• SmithY.KievalJZ.Anatomy of the dopamine system in the basal ganglia.Trends Neurosci200023(10, suppl)S28S3311052217
   PubMed Web of Science ®Google Scholar
• BraakH.Del TrediciK.RubU.de VosRA.Jansen SteurEN.BraakE.Staging of brain pathology related to sporadic Parkinson's disease.Neurobiol Aging20032419721112498954
   PubMed Web of Science ®Google Scholar
• ZarowC.LynessSA.MortimerJA.ChuiHC.Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.Arch Neurol20036033734112633144
   PubMed Web of Science ®Google Scholar
• BertrandE.LechowiczW.SzpakGM.DymeckiJ.Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.Folia Neuropathol19973580869377080
   PubMed Web of Science ®Google Scholar
• HallidayGM.LiYW.BlumbergsPC.et al.Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.Ann Neurol1990273733851972319
   PubMed Web of Science ®Google Scholar
• BerridgeCW.WaterhouseBD.The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes.Brain Res Brain Res Rev200342338412668290
   PubMed Web of Science ®Google Scholar
• GinsbergSD.HofPR.YoungWG.MorrisonJH.Noradrenergic innervation of the hypothalamus of rhesus monkeys: distribution of dopamine-phydroxylase immunoreactlve fibers and quantitative analysis of varicosities in the paraventricular nucleus.J Comp Neurol19933275976118440783
   PubMed Web of Science ®Google Scholar
• KishSJ.ShannakKS.RajputAH.GilbertJJ.HornykiewiczO.Cerebellar norepinephrine in patients with Parkinson's disease and control subjects.Arch Neurol1984416126146721735
   PubMedGoogle Scholar
• OnofrjM.ThomasA.D'AndreamatteoG.et al.Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up.Neurol Sci200223(suppl 2)S91S9412548359
   PubMed Web of Science ®Google Scholar
• OlsonEJ.BoeveBF.SilberMH.Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.Brain2000123(pt2)33133910648440
   PubMed Web of Science ®Google Scholar
• TrenkwalderC.Sleep dysfunction in Parkinson's disease.Clin Neurosci1998510711410785836
   PubMedGoogle Scholar
• SchenckCH.BundlieSR.MahowaldMW.Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.Neurology1996463883938614500
   PubMed Web of Science ®Google Scholar
• ZweigRM.JankelWR.HedreenJC.MayeuxR.PriceDL.The pedunculopontine nucleus in Parkinson's disease.Ann Neurol19892641462549845
   PubMed Web of Science ®Google Scholar
• JellingerKA.Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.Mol Chern Neuropathol199114153197
   PubMed Web of Science ®Google Scholar
• LavoieB.ParentA.Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons.J Comp Neurol19943441902097915726
   PubMed Web of Science ®Google Scholar
• NakanoK.HasegawaY.TokushigeA.NakagawaS.KayaharaT.MizunoN.Topographical projections from the thalamus, subthalamic nucleus and pedunculopontine tegmental nucleus to the striatum in the Japanese monkey, Macaca fuscata. Brain Res199053754681707734
   PubMed Web of Science ®Google Scholar
• MatsumuraM.NambuA.YamajiY.et al.Organization of somatic motor inputs from the frontal lobe to the pedunculopontine tegmental nucleus in the macaque monkey.Neuroscience2000989711010858616
   PubMed Web of Science ®Google Scholar
• ShinkE.SidibeM.SmithY.Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus.J Comp Neurol19973823483639183698
   PubMed Web of Science ®Google Scholar
• MontiJM.MontiD.Role of dorsal raphe nucleus serotonin 5-HTia receptor in the regulation of REM sleep.Life Sci2000661999201210823340
   PubMed Web of Science ®Google Scholar
• RyeDB.Contributions of the pedunculopontine region to normal and altered REM sleep.Sleep1997207577889406329
   PubMed Web of Science ®Google Scholar
• TakakusakiK.SaitohK.HaradaH.OkumuraT.SakamotoT.Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.Neuroscience200412420722014960352
   PubMed Web of Science ®Google Scholar
• KojimaJ.YamajiY.MatsumuraM.et al.Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey.Neurosci Lett19972261111149159502
   PubMed Web of Science ®Google Scholar
• MatsumuraM.KojimaJ.The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.Stereotact Funct Neurosurg20017710811512378066
   PubMed Web of Science ®Google Scholar
• NandiD.LiuX.WinterJL.AzizTZ.SteinJF.Deep brain stimulation of the pedunculopontine region in the normal non-human primate.J Clin Neurosci2002917017411922707
   PubMed Web of Science ®Google Scholar
• NandiD.AzizTZ.GiladiN.WinterJ.SteinJF.Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus.Brain2002125(pt 11)2418243012390969
   PubMed Web of Science ®Google Scholar
• GasparP.GrayF.Dementia in idiopathic Parkinson's disease. A neuropathology I study of 32 cases.Acta Neuropathol (Bed)1984644352
   PubMed Web of Science ®Google Scholar
• GibbWR.Dementia and Parkinson's disease.Br J Psychiatry19891545966142557109
   PubMed Web of Science ®Google Scholar
• MayeuxR.Epidemiology of neurodegeneration.Annu Rev Neurosci2003268110412574495
   PubMed Web of Science ®Google Scholar
• CandyJM.PerryRH.PerryEK.et al.Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.J Neurol Sci1983592772896854353
   PubMed Web of Science ®Google Scholar
• HardingAJ.StimsonE.HendersonJM.HallidayGM.Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease.Brain2002125(pt 11)2431244512390970
   PubMed Web of Science ®Google Scholar
• BraakH.BraakE.YilmazerD.et al.Amygdala pathology in Parkinson's disease.Acta Neuropathol (Berl)1994884935007879596
   PubMed Web of Science ®Google Scholar
• McDonaldAJ.Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: colocalization of excitatory amino acids and projections to the limbic circuit.J Comp Neurol19963653673798822176
   PubMed Web of Science ®Google Scholar
• CardinalRN.ParkinsonJA.HallJ.EverittBJ.Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex.Neurosci BiobehavRev200226321352
   PubMed Web of Science ®Google Scholar
• MacDonaldV.HallidayGM.Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.Mov Disord2002171166117312465053
   PubMed Web of Science ®Google Scholar
• HendersonJM.CarpenterK.CartwrightH.HallidayGM.Degeneration of the centre median-parafascicular complex in Parkinson's disease.Ann Neurol20004734535210716254
   PubMed Web of Science ®Google Scholar
• PurbaJS.HofmanMA.SwaabDF.Decreased number of oxytocinimmunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease.Neurology19944484897904735
   PubMed Web of Science ®Google Scholar
• AnsorgeO.DanielSE.PearceRK.Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease.Neurology1997496106139270609
   PubMed Web of Science ®Google Scholar
• HughesAJ.DanielSE.BlanksonS.LeesAJ.A clinicopathologic study of 100 cases of Parkinson's disease.Arch Neurol1993501401488431132
   PubMed Web of Science ®Google Scholar
• ColosimoC.HughesAJ.KilfordL.LeesAJ.Lewy body cortical involvement may not always predict dementia in Parkinson's disease.J Neurol Neurosurg Psychiatry20037485285612810766
   PubMed Web of Science ®Google Scholar
• GibbWR.LuthertPJ.JanotaI.LantosPL.Cortical Lewy body dementia: clinical features and classification.J Neurol Neurosurg Psychiatry1989521851922467966
   PubMed Web of Science ®Google Scholar
• PerryR.McKeithI.PerryE.Lewy body dementia - clinical, pathological and neurochemical interconnections.J Neural Transm Suppl199751951099470131
   PubMedGoogle Scholar
• ChaudhuriKR.Autonomic dysfunction in movement disorders.Curr Opin Neurol20011450551111470968
   PubMed Web of Science ®Google Scholar
• MicieliG.TosiP.MarcheselliS.CavalliniA.Autonomic dysfunction in Parkinson's disease.Neurol Sci200324(suppl 1)S32S3412774210
   PubMed Web of Science ®Google Scholar
• WakabayashiK.TakahashiH.Neuropathology of autonomic nervous system in Parkinson's disease.Eur Neurol199738(suppl 2)279387796
   PubMed Web of Science ®Google Scholar
• EdwardsLL.QuigleyEM.PfeifferRF.Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.Neurology1992427267321565224
   PubMed Web of Science ®Google Scholar
• JohnstonBT.LiQ.CastellJA.CastellDO.Swallowing and esophageal function in Parkinson's disease. Ami.Gastroenterol19959017411746
   Web of Science ®Google Scholar
• HilaA.CastellJA.CastellDO.Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphagia.J Clin Gastroenterol20013335536111606849
   PubMed Web of Science ®Google Scholar
• WakabayashiK.TakahashiH.The intermediolateral nucleus and Clarke's column in Parkinson's disease.Acta Neuropathol (Berl)1997942872899292699
   PubMed Web of Science ®Google Scholar
• DruschkyA.HilzMJ.PlatschG.et al.Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of 1-123MIBG-SPECT.J Neurol Sci200017531210785250
   PubMed Web of Science ®Google Scholar
• CourbonF.Brefel-CourbonC.et al.Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.Mov Disord20031889089712889078
   PubMed Web of Science ®Google Scholar
• OrimoS.OkaT.MiuraH.et al.Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy.J Neurol Neurosurg Psychiatry20027377677712438492
   PubMed Web of Science ®Google Scholar
• JennerP.Oxidative stress in Parkinson's disease.Ann Neurol200353(suppl 3)S26S3612666096
   PubMedGoogle Scholar
• EbadiM.SharmaSK.Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.Antioxid Redox Signal2003531933512880486
   PubMed Web of Science ®Google Scholar
• KoutsilieriE.SchellerC.GrunblattE.NaraK.LiJ.RiedererP.Free radicals in Parkinson's disease.J Neurol2002249(suppl 2)111115
   Google Scholar
• GreenamyreJT.MacKenzieG.PengTl.StephansSE.Mitochondrial dysfunction in Parkinson's disease.Biochem Soc Symp199966859710989660
   PubMedGoogle Scholar
• McNaughtKS.OlanowCW.Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.Ann Neurol200353(suppl 3)S73S8412666100
   PubMed Web of Science ®Google Scholar
• HoglingerGU.CarrardG.MichelPP.et al.Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.J Neurochem2003861297130712911637
   PubMed Web of Science ®Google Scholar
• GaoHM.LiuB.ZhangW.HongJS.Novel anti-inflammatory therapy for Parkinson's disease.Trends Pharmacol Sci20032439540112915048
   PubMed Web of Science ®Google Scholar
• HunotS.HirschEC.Neuroinflammatory processes in Parkinson's disease.Ann Neurol200353(suppl 3)S49S5812666098
   PubMedGoogle Scholar
• OrrCF.RoweDB.HallidayGM.An inflammatory review of Parkinson's disease.Prog Neurobiol20026832534012531233
   PubMed Web of Science ®Google Scholar
• VilaM.PrzedborskiS.Targeting programmed cell death in neurodegenerative diseases.Nat Rev Neurosci2003436537512728264
   PubMed Web of Science ®Google Scholar
• JennerP.Parkinson's disease, pesticides and mitochondrial dysfunction.Trends Neurosci20012424524711311359
   PubMed Web of Science ®Google Scholar
• Di MonteDA.LavasaniM.Manning-BogAB.Environmental factors in Parkinson's disease.Neurotoxicology20022348750212428721
   PubMed Web of Science ®Google Scholar
• BetarbetR.ShererTB.Di MonteDA.GreenamyreJT.Mechanistic approaches to Parkinson's disease pathogenesis.Brain Pathol20021249951012408237
   PubMed Web of Science ®Google Scholar
• RichterG.SonnenscheinA.GrunewaldT.ReichmannH.JanetzkyB.Novel mitochondrial DNA mutations in Parkinson's disease.J Neural Transm200210972172912111463
   PubMed Web of Science ®Google Scholar
• MellickGD.SilburnPA.PrinceJA.BrookesAJ.A novel screen for nuclear mitochondrial gene associations with Parkinson's disease.J Neural Transm200411119119914767722
   PubMed Web of Science ®Google Scholar
• DekkerMC.BonifatiV.van DuijnCM.Parkinson's disease: piecing together a genetic jigsaw.Brain2003126(pt 8)1722173312805097
   PubMed Web of Science ®Google Scholar
• MouradianMM.Recent advances in the genetics and pathogenesis of Parkinson disease.Neurology20025817918511805242
   PubMed Web of Science ®Google Scholar
• Gwinn-HardyK.Genetics of parkinsonism.Mov Disord20021764565612210852
   PubMed Web of Science ®Google Scholar
• AlvesDC.Recent advances on a-synuclein cell biology: functions and dysfunctions.Curr Mol Med20033172412558071
   PubMed Web of Science ®Google Scholar
• BonifatiV.OostraBA.HeutinkP.Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.J Mol Med20048216317414712351
   PubMed Web of Science ®Google Scholar
• LeWD.XuP.JankovicJ.et al.Mutations in NR4A2 associated with familial Parkinson disease.Nat Genet200333858912496759
   PubMed Web of Science ®Google Scholar
• XuPY.LiangR.JankovicJ.et al.Association of homozygous 7048G7049 variant in the intron six of Nurr1gene with Parkinson's disease.Neurology20025888188411914402
   PubMed Web of Science ®Google Scholar
• ZhengK.HeydariB.SimonDK.A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.Arch Neurol20036072272512756136
   PubMedGoogle Scholar
• EellsJB.The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease.Curr Med Chern200310857870
   PubMed Web of Science ®Google Scholar
• LeW.ConneelyOM.ZouL.et al.Selective agenesis of mesencephalic dopaminergic neurons in Nurr1 -deficient mice.Exp Neurol199915945145810506516
   PubMed Web of Science ®Google Scholar
• SimonHH.BhattL.GherbassiD.SgadoP.AlberiL.Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.Ann N Y Acad Sci2003991364712846972
   PubMed Web of Science ®Google Scholar
• GoridisC.RohrerH.Specification of catecholaminergic and serotonergic neurons.Nat Rev Neurosci2002353154112094209
   PubMed Web of Science ®Google Scholar
• LimKL.DawsonVL.DawsonTM.The genetics of Parkinson's disease.Curr Neurol Neurosci Rep2002243944612169225
   PubMedGoogle Scholar
• WarnerTT.SchapiraAH.Genetic and environmental factors in the cause of Parkinson's disease.Ann Neurol200353(suppl 3)S16S2312666095
   PubMed Web of Science ®Google Scholar
• HauserMA.LiYJ.TakeuchiS.et al.Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage.Hum MolGenet200312671677
   PubMed Web of Science ®Google Scholar
• OliveiraSA.ScottWK.MartinER.et al.Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.Ann Neurol20035362462912730996
   PubMed Web of Science ®Google Scholar
• MaraganoreDM.LesnickTG.ElbazA.et al. UCHL1 is a Parkinson's disease susceptibility gene..Ann Neurol20045551252115048890
   PubMed Web of Science ®Google Scholar
• CarmineA.BuervenichS.GaiterD.et al.NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.Am J Med Genet20031206515712815740
   PubMedGoogle Scholar
• OliveiraSA.ScottWK.NanceMA.et al.Association study of parkin gene polymorphisms with idiopathic Parkinson disease.Arch Neurol20036097598012873854
   PubMedGoogle Scholar
• van der WaltJM.MartinER.ScottWK.et al.Genetic polymorphisms of the W-acetyltransferase genes and risk of Parkinson's disease.Neurology2003601189119112682333
   PubMed Web of Science ®Google Scholar
• OliveriRL.ZappiaM.AnnesiG.et al.The parkin gene is not involved in late-onset Parkinson's disease.Neurology20015735936211468333
   PubMed Web of Science ®Google Scholar
• TannerCM.OttmanR.GoldmanSM.et al.Parkinson disease in twins: an etiologic study.JAMA19992813413469929087
   PubMed Web of Science ®Google Scholar
• WirdefeldtK.GatzM.SchallingM.PedersenNL.No evidence for heritability of Parkinson disease in Swedish twins.Neurology200463305311 15277625
   PubMed Web of Science ®Google Scholar
• MatsunagaM.ShiraneY.AiuchiT.NakamuraY.NakayaK.Uptake of 1-methyl-4-phenylpyridinium ion (MPP+) and ATP content in synaptosomes.BiolPharrn Bull1996192933
   Google Scholar
• CollinsMA.NeafseyEJ.Potential neurotoxic “agents provocateurs” in Parkinson's disease.Neurotoxicoi Teratoi200224571577
   PubMed Web of Science ®Google Scholar
• ThiruchelvamM.McCormackA.RichfieldEK.et al.Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.Eur J Neurosci20031858960012911755
   PubMed Web of Science ®Google Scholar
• ShererTB.BetarbetR.TestaCM.et al.Mechanism of toxicity in rotenone models of Parkinson's disease.J Neurosci200323107561076414645467
   PubMed Web of Science ®Google Scholar
• GreenamyreJT.BetarbetR.ShererTB.The rotenone model of Parkinson's disease: genes, environment and mitochondria.Parkinsonism Relat Disord20039(suppl 2)S59S6412915069
   PubMed Web of Science ®Google Scholar
• BetarbetR.ShererTB.MacKenzieG.Garcia-OsunaM.PanovAV.GreenamyreJT.Chronic systemic pesticide exposure reproduces features of Parkinson's disease.Nat Neurosci200031301130611100151
   PubMed Web of Science ®Google Scholar
• ShererTB.KimJH.BetarbetR.GreenamyreJT.Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and a-synuclein aggregation.Exp Neurol200317991612504863
   PubMed Web of Science ®Google Scholar
• RitzB.YuF.Parkinson's disease mortality and pesticide exposure in California 1984-1994.Int J Epidemiol20002932332910817132
   PubMed Web of Science ®Google Scholar
• SchultePA.BurnettCA.BoenigerMF.JohnsonJ.Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.Am J Public Health199686128112888806381
   PubMed Web of Science ®Google Scholar
• GuM.OwenAD.ToffaSE.et al.Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.J Neurol Sci199815824299667773
   PubMed Web of Science ®Google Scholar
• SianJ.DexterDT.LeesAJ.et al.Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.Ann Neurol1994363483558080242
   PubMed Web of Science ®Google Scholar
• ZhangJ.PerryG.SmithMA.et al.Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.Am J Pathol19991541423142910329595
   PubMed Web of Science ®Google Scholar
• CastellaniR.SmithMA.RicheyPL.PerryG.Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.Brain Res19967371952008930366
   PubMed Web of Science ®Google Scholar
• FesselJP.HuletteC.PowellS.RobertsLJ.ZhangJ.Isofurans, but not F2isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease.J Neurochem20038564565012694390
   PubMed Web of Science ®Google Scholar
• AlamZl.DanielSE.LeesAJ.MarsdenDC.JennerP.HalliwellB.A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.J Neurochem199769132613299282961
   PubMed Web of Science ®Google Scholar
• LothariusJ.BrundinP.Pathogenesis of Parkinson's disease: dopamine, vesicles and a-synuclein.Nat Rev Neurosci2002393294212461550
   PubMed Web of Science ®Google Scholar
• BarzilaiA.MelamedE.Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.Trends Moi Med2003912613212657434
   PubMed Web of Science ®Google Scholar
• AlamZl.JennerA.DanielSE.et al.Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.J Neurochem199769119612039282943
   PubMed Web of Science ®Google Scholar
• GoodPF.HsuA.WernerP.PerlDP.OlanowCW.Protein nitration in Parkinson's disease.J Neuropathol Exp Neurol1998573383429600227
   PubMed Web of Science ®Google Scholar
• DoubleKL.GerlachM.YoudimMB.RiedererP.Impaired iron homeostasis in Parkinson's disease.J Neural Transm Suppl200060375811205155
   PubMedGoogle Scholar
• LogroscinoG.MarderK.GrazianoJ.et al.Altered systemic iron metabolism in Parkinson's disease.Neurology1997497147179305329
   PubMed Web of Science ®Google Scholar
• RiedererP.SoficE.RauschWD.et al.Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.J Neurochem1989525155202911028
   PubMed Web of Science ®Google Scholar
• DoubleKL.Ben ShacharD.YoudimMB.ZeccaL.RiedererP.GerlachM.Influence of neuromelanin on oxidative pathways within the human substantia nigra.Neurotoxicoi Teratoi200224621628
   PubMed Web of Science ®Google Scholar
• FaucheuxBA.MartinME.BeaumontC.et al.Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.J Neurochem20028332033012423242
   PubMed Web of Science ®Google Scholar
• ZeccaL.ZuccaFA.WilmsH.SulzerD.Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics.Trends Neurosci20032657858014585596
   PubMed Web of Science ®Google Scholar
• MarcoFD.FoppoliC.CocciaR.et al.Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation.Biochern Biophys Res Commun2004314631637
   PubMed Web of Science ®Google Scholar
• DevKK.HofeleK.BarbieriS.BuchmanVL.van derPH.Part II: a-synuclein and its molecular pathophysiological role in neurodegenerative disease.Neuropharmacology200345144412814657
   PubMed Web of Science ®Google Scholar
• TrojanowskiJQ.GoedertM.IwatsuboT.LeeVM.Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.Cell Death Differ1998583283710203692
   PubMed Web of Science ®Google Scholar
• KaplanB.RatnerV.HaasE.a-Synuclein: its biological function and role in neurodegenerative diseases.J Mol Neurosci200320839212794302
   PubMed Web of Science ®Google Scholar
• ClaytonDF.GeorgeJM.Synucleins in synaptic plasticity and neurodegenerative disorders.J Neurosci Res19995812012910491577
   PubMed Web of Science ®Google Scholar
• TofarisGK.RazzaqA.GhettiB.LilleyKS.SpillantiniMG.Ubiquitination of α-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.J Biol Chern20032784440544411
   PubMed Web of Science ®Google Scholar
• RochetJC.OuteiroTF.ConwayKA.et al.Interactions among a-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.J Mol Neurosci200423233415126689
   PubMed Web of Science ®Google Scholar
• LothariusJ.BrundinP.Impaired dopamine storage resulting from asynuclein mutations may contribute to the pathogenesis of Parkinson's disease.Hum Mol Genet2002112395240712351575
   PubMed Web of Science ®Google Scholar
• ShtilermanMD.DingTT.LansburyPT Jr.Molecular crowding accelerates f ibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?Biochemistry2002413855386011900526
   PubMed Web of Science ®Google Scholar
• RiessO.BergD.KrugerR.SchulzJB.Therapeutic strategies for Parkinson's disease based on data derived from genetic research.J Neurol2003250(suppl 1)13110
   Web of Science ®Google Scholar
• EbadiM.GovitrapongP.SharmaS.et al.Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.Biol Signals Recept20011022425311351130
   PubMedGoogle Scholar
• ImamuraK.HishikawaN.SawadaM.NagatsuT.YoshidaM.HashizumeY.Distribution of major histocompatibility complex class ll-positive microglia and cytokine profile of Parkinson's disease brains.Acta Neuropathol (Berl)200310651852614513261
   PubMed Web of Science ®Google Scholar
• WudC.TieuK.CohenO.et al.Glial cell response: a pathogenic factor in Parkinson's disease.J Neurovirol2002855155812476349
   PubMed Web of Science ®Google Scholar
• LeW.RoweD.XieW.OrtizI.HeY.AppelSH.Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.J Neurosci2001218447845511606633
   PubMed Web of Science ®Google Scholar
• HealesSJ.LamAA.DuncanAJ.LandJM.Neurodegeneration or neuroprotection: the pivotal role of astrocytes.Neurochem Res20042951351915038599
   PubMed Web of Science ®Google Scholar
• HunotS.DugasN.FaucheuxB.et al.FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-a in glial cells.J Neurosci1999193440344710212304
   PubMed Web of Science ®Google Scholar
• BealMF.Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis.Ann Neurol199844(3, suppl 1)S110S1149749581
   PubMedGoogle Scholar
• NagatsuT.MogiM.IchinoseH.TogariA.Cytokines in Parkinson's disease.J Neural Transm Suppl200058143151 11128604
   PubMedGoogle Scholar
• BokaG.AngladeP.WallachD.Javoy-AgidF.AgidY.HirschEC.Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.Neurosci Lett19941721511548084523
   PubMed Web of Science ®Google Scholar
• MogiM.TogariA.KondoT.et al.Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. 7.Neural Transm2000107335341
   PubMed Web of Science ®Google Scholar
• AngladeP.VyasS.Javoy-AgidF.et al.Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.Histol Histopathol19971225319046040
   PubMed Web of Science ®Google Scholar
• NagatsuT.Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy.J Neural Transm200210973174512111464
   PubMed Web of Science ®Google Scholar
• TompkinsMM.BasgallEJ.ZamriniE.HillWD.Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.Am J Pathol19971501191319006329
   PubMed Web of Science ®Google Scholar
• HartmannA.Mouatt-PrigentA.FaucheuxBA.AgidY.HirschEC.FADD: a link between TNF family receptors and caspases in Parkinson's disease.Neurology20025830831011805265
   PubMed Web of Science ®Google Scholar
• MandelS.GrunblattE.RiedererP.GerlachM.LévitesY.YoudimMB.Neuroprotective strategies in Parkinson's disease: an update on progress.CNS Drugs20031772976212873156
   PubMed Web of Science ®Google Scholar
• SchapiraAH.OlanowCW.Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.JAMA200429135836414734599
   PubMed Web of Science ®Google Scholar
• JennerP.The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease.Parkinsonismi Relat Disord20039131137
   PubMed Web of Science ®Google Scholar
• StocchiF.OlanowCW.Neuroprotection in Parkinson's disease: clinical trials.Ann Neurol200353(suppl 3)S87S9712666101
   PubMed Web of Science ®Google Scholar
• BergmanH.WichmannT.KarmonB.DeLongMR.The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.J Neurophysiol1994725075207983515
   PubMed Web of Science ®Google Scholar
• FilionM.TremblayL.Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.Brain Res19915471421511677607
   PubMed Web of Science ®Google Scholar
• DeLongMR.Primate models of movement disorders of basal ganglia origin.Trends Neurosci1990132812851695404
   PubMed Web of Science ®Google Scholar
• FilionM.TremblayL.BedardPJ.Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTPinduced parkinsonism.Brain Res19915471521611677608
   PubMed Web of Science ®Google Scholar
• BergmanH.WichmannT.DeLongMR.Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.Science1990249143614382402638
   PubMed Web of Science ®Google Scholar
• WichmannT.BergmanH.DeLongMR.The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.J Neurophysiol1994725215307983516
   PubMed Web of Science ®Google Scholar
• BaronMS.VitekJL.BakayRA.et al.Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study.Ann Neurol1996403553668797525
   PubMed Web of Science ®Google Scholar
• SamuelM.Ceballos-BaumannAO.TurjanskiN.et al.Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2 15 O PET study.Brain1997120(pt 8)130113139278624
   PubMed Web of Science ®Google Scholar
• KumarR.LangAE.Rodriguez-OrozMC.etal.Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease.Neurology200055(12, suppl 6)S34S3911188973
   PubMed Web of Science ®Google Scholar
• Limousin-DowseyP.PollakP.Van BlercomN.KrackP.BenazzouzA.BenabidA.Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease.J Neurol1999246(suppl 2)11421145
   Web of Science ®Google Scholar
• BenabidAL.KoudsieA.BenazzouzA.et al.Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy.J Neurol2001248(suppl 3)1113711147
   Google Scholar
• BenabidAL.PollakP.GrossC.et al.Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.Stereotact Fund Neurosurg1994627684
   PubMedGoogle Scholar
• RodriguezMC.GuridiOJ.AlvarezL.et al.The subthalamic nucleus and tremor in Parkinson's disease.Mov Disord199813(suppl 3)1111189827606
   PubMed Web of Science ®Google Scholar
• GuridiJ.ObesoJA.The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma.Brain2001124(pt 1)51911133783
   PubMed Web of Science ®Google Scholar
• PatelNK.HeywoodP.O'SullivanK.McCarterR.LoveS.GillSS.Unilateral subthalamotomy in the treatment of Parkinson's disease.Brain2003126(pt 5)1136114512690053
   PubMed Web of Science ®Google Scholar
• ChenCC.LeeST.WuT.ChenCJ.HuangCC.LuCS.Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases.Mov Disord2002171367137112465086
   PubMedGoogle Scholar
• SuPC.TsengHM.LiuHM.YenRF.LiouHH.Treatment of advanced Parkinson's disease by subthalamotomy: 1-year results.Mov Disord20031853153812722167
   PubMed Web of Science ®Google Scholar
• AlexanderGE.CrutcherMD.DeLongMR.Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions.Prog Brain Res1990851191462094891
   PubMed Web of Science ®Google Scholar
• AlexanderGE.CrutcherMD.Functional architecture of basal ganglia circuits: neural substrates of parallel processing.Trends Neurosci199013266271 1695401
   PubMed Web of Science ®Google Scholar
• HooverJE.StrickPL.Multiple output channels in the basal ganglia.Science19932598198217679223
   PubMed Web of Science ®Google Scholar
• MiddletonFA.StrickPL.Basal ganglia and cerebellar loops: motor and cognitive circuits.Brain Res Brain Res Rev20003123625010719151
   PubMed Web of Science ®Google Scholar
• KellyRM.StrickPL.Macro-architecture of basal ganglia loops with the cerebral cortex: use of rabies virus to reveal multisynaptic circuits.Prog Brain Res200414344945914653187
   PubMed Web of Science ®Google Scholar
• LehericyS.DucrosM.Van de MoortelePF.et al.Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans.Ann Neurol20045552252915048891
   PubMed Web of Science ®Google Scholar
• MonchiO.PetridesM.DoyonJ.PostumaRB.WorsleyK.DagherA.Neural bases of set-shifting deficits in Parkinson's disease.J Neurosci20042470271014736856
   PubMed Web of Science ®Google Scholar
• MiddletonFA.StrickPL.Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies.Brain Cogn20004218320010744919
   PubMed Web of Science ®Google Scholar
• Ceballos-BaumannAO.Functional imaging in Parkinson's disease: activation studies with PET, fMRI, and SPECT.J Neurol2003250(suppl 1)115123
   Web of Science ®Google Scholar
• CarbonM.MarieRM.Functional imaging of cognition in Parkinson's disease.Curr Opin Neurol20031647548012869806
   PubMed Web of Science ®Google Scholar
• JahanshahiM.RoweJ.SaleemT.et al.Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy.J Cogn Neurosci20021429831011970793
   PubMed Web of Science ®Google Scholar
• LewisSJ.DoveA.RobbinsTW.BarkerRA.OwenAM.Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.J Neurosci2003236351635612867520
   PubMed Web of Science ®Google Scholar
• StefurakT.MikulisD.MaybergH.et al.Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study.Mov Disord2003181508151614673888
   PubMed Web of Science ®Google Scholar
• Saint-CyrJA.Frontal-striatal circuit functions: context, sequence, and consequence.J Int Neuropsychol Soc2003910312712570364
   PubMed Web of Science ®Google Scholar
• SamuelM.Ceballos-BaumannAO.BoeckerH.BrooksDJ.Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study.Neuroreport20011282182811277590
   PubMed Web of Science ®Google Scholar
• Cronin-GolombA.BraunAE.Visuospatial dysfunction and problem solving in Parkinson's disease.Neuropsychology19971144529055268
   PubMed Web of Science ®Google Scholar
• PillonB.CzerneckiV.DuboisB.Dopamine and cognitive function.Curr Opin Neurol200316(suppl 2)S17S2215129846
   PubMed Web of Science ®Google Scholar
• CrevitsL.VandierendonckA.StuyvenE.VerschaeteS.WildenbeestJ.Effect of intention and visual fixation disengagement on prosaccades in Parkinson's disease patients.Neuropsychoiogia200442624632
   PubMed Web of Science ®Google Scholar
• ThielA.HilkerR.KesslerJ.HabedankB.HerholzK.HeissWD.Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study.J Neural Transm20031101289130114628193
   PubMedGoogle Scholar
• HodgsonTL.TiesmanB.OwenAM.KennardC.Abnormal gaze strategies during problem solving in Parkinson's disease.Neuropsychoiogia200240411422
   PubMed Web of Science ®Google Scholar
• ZgaljardicDJ.BorodJC.FoldiNS.MattisP.A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.Cogn Behav Neurol20031619321014665819
   PubMedGoogle Scholar
• AlcantaraAA.MrzljakL.JakabRL.LeveyAI.HerschSM.Goldman-RakicPS.Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways.J Comp Neurol200143444546011343292
   PubMed Web of Science ®Google Scholar
• DescarriesL.WatkinsKC.GarciaS.BoslerO.DoucetG.Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis.J Comp Neurol19963751671868915824
   PubMed Web of Science ®Google Scholar
• HerschSM.CiliaxBJ.GutekunstCA.et al.Electron microscopic analysis of Di and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afférents.J Neurosci199515(7, pt 2)522252377623147
   PubMed Web of Science ®Google Scholar
• YungKK.BolamJP.Localization of dopamine Di and D2 receptors in the rat neostriatum: synaptic interaction with glutamate- and GABA-containing axonal terminals.Synapse20003841342011044888
   PubMed Web of Science ®Google Scholar
• GreengardP.The neurobiology of slow synaptic transmission.Science20012941024103011691979
   PubMed Web of Science ®Google Scholar
• MissaleC.NashSR.RobinsonSW.JaberM.CaronMG.Dopamine receptors: from structure to function.Physiol Rev1998781892259457173
   PubMed Web of Science ®Google Scholar
• SvenningssonP.NishiA.FisoneG.GiraultJA.NairnAC.GreengardP.DARPP-32: an integrator of neurotransmission.Annu Rev Pharmacol Toxicol20044426929614744247
   PubMed Web of Science ®Google Scholar
• NishiA.BibbJA.MatsuyamaS.et al.Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.J Neurochem20028183284112065642
   PubMed Web of Science ®Google Scholar
• OuimetCC.GreengardP.Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.J Neurocytol19901939522191086
   PubMedGoogle Scholar
• OuimetCC.Langley-GullionKC.GreengardP.Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen.Brain Res19988088129795103
   PubMed Web of Science ®Google Scholar
• HaberSN.FudgeJL.McFarlandNR.Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum.J Neurosci2000202369238210704511
   PubMed Web of Science ®Google Scholar
• SchultzW.DickinsonA.Neuronal coding of prediction errors.Annu Rev Neurosci20002347350010845072
   PubMed Web of Science ®Google Scholar
• SchultzW.Predictive reward signal of dopamine neurons.J Neurophysiol1998801279658025
   PubMed Web of Science ®Google Scholar
• SuriRE.SchultzW.Temporal difference model reproduces anticipatory neural activity.Neural Comput20011384186211255572
   PubMed Web of Science ®Google Scholar
• CalabresiP.GubelliniP.CentonzeD.et al.Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity.J Neurosci2000208443845111069952
   PubMed Web of Science ®Google Scholar
• NambuA.KanedaK.TokunoH.TakadaM.Organization of corticostriatal motor inputs in monkey putamen.J Neurophysiol2002881830184212364509
   PubMed Web of Science ®Google Scholar
• InaseM.TokunoH.NambuA.AkazawaT.TakadaM.Corticostriatal and corticosubthalamic input zones from the presupplementary motor area in the macaque monkey: comparison with the input zones from the supplementary motor area.Brain Res199983319120110375694
   PubMed Web of Science ®Google Scholar
• TakadaM.TokunoH.NambuA.InaseM.Corticostriatal input zones from the supplementary motor area overlap those from the contra- rather than ipsilateral primary motor cortex.Brain Res19987913353409593979
   PubMed Web of Science ®Google Scholar
• TakadaM.TokunoH.NambuA.InaseM.Corticostriatal projections from the somatic motor areas of the frontal cortex in the macaque monkey: segregation versus overlap of input zones from the primary motor cortex, the supplementary motor area, and the premotor cortex.Exp Brain Res19981201141289628410
   PubMed Web of Science ®Google Scholar
• YeterianEH.PandyaDN.Corticostriatal connections of the superior temporal region in rhesus monkeys.J Comp Neurol19983993844029733085
   PubMed Web of Science ®Google Scholar
• ChengK.SaleemKS.TanakaK.Organization of corticostriatal and corticoamygdalar projections arising from the anterior inferotemporal area TE of the macaque monkey: a Phaseolus vulgaris leucoagglutinin study.J Neurosci199717790279259315910
   PubMed Web of Science ®Google Scholar
• InaseM.SakaiST.TanjiJ.Overlapping corticostriatal projections from the supplementary motor area and the primary motor cortex in the macaque monkey: an anterograde double labeling study.J Comp Neurol19963732832968889928
   PubMed Web of Science ®Google Scholar
• YeterianEH.PandyaDN.Corticostriatal connections of extrastriate visual areas in rhesus monkeys.J Comp Neurol19953524364577706560
   PubMed Web of Science ®Google Scholar
• ParthasarathyHB.SchallJD.GraybielAM.Distributed but convergent ordering of corticostriatal projections: analysis of the frontal eye field and the supplementary eye field in the macaque monkey.J Neurosci199212446844881279139
   PubMed Web of Science ®Google Scholar
• CavadaC.Goldman-RakicPS.Topographic segregation of corticostriatal projections from posterior parietal subdivisions in the macaque monkey.Neuroscience1991426836961720224
   PubMed Web of Science ®Google Scholar
• FlahertyAW.GraybielAM.Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped bodypart representations.J Neurophysiol199166124912631722244
   PubMed Web of Science ®Google Scholar
• YeterianEH.PandyaDN.Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys.J Comp Neurol199131243671744243
   PubMed Web of Science ®Google Scholar
• SelemonLD.Goldman-RakicPS.Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey.J Neurosci198557767942983048
   PubMed Web of Science ®Google Scholar
• KanedaK.NambuA.TokunoH.TakadaM.Differential processing patterns of motor information via striatopallidal and striatonigral projections.J Neurophysiol2002881420143212205163
   PubMed Web of Science ®Google Scholar
• SidibeM.SmithY.Differential synaptic innervation of striatofugal neurones projecting to the internal or external segments of the globus pallidus by thalamic afférents in the squirrel monkey.J Comp Neurol19963654454658822181
   PubMed Web of Science ®Google Scholar
• YelnikJ.FrancoisC.PercheronG.TandeD.A spatial and quantitative study of the striatopallidal connection in the monkey.Neuroreport199679859888804036
   PubMed Web of Science ®Google Scholar
• Lynd-BaltaE.HaberSN.Primate striatonigral projections: a comparison of the sensorimotor-related striatum and the ventral striatum.J Comp Neurol19943455625787962700
   PubMed Web of Science ®Google Scholar
• FlahertyAW.GraybielAM.Output architecture of the primate putamen.J Neurosci199313322232377688037
   PubMed Web of Science ®Google Scholar
• HazratiLN.ParentA.The striatopallidal projection displays a high degree of anatomical specificity in the primate.Brain Res19925922132271450912
   PubMed Web of Science ®Google Scholar
• HedreenJC.DeLongMR.Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque.J Comp Neurol19913045695952013650
   PubMed Web of Science ®Google Scholar
• Gimenez-AmayaJM.GraybielAM.Compartmental origins of the striatopallidal projection in the primate.Neuroscience1990341111261691462
   PubMed Web of Science ®Google Scholar
• SelemonLD.Goldman-RakicPS.Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey.J Comp Neurol19902973593761697864
   PubMed Web of Science ®Google Scholar
• SidibeM.PareJF.SmithY.Nigral and pallidal inputs to functionally segregated thalamostriatal neurons in the centromedian/parafascicular intralaminar nuclear complex in monkey.J Comp Neurol200244728629911984822
   PubMed Web of Science ®Google Scholar
• BaronMS.SidibeM.DeLongMR.SmithY.Course of motor and associative pallidothalamic projections in monkeys.J Comp Neurol200142949050111116233
   PubMed Web of Science ®Google Scholar
• SakaiST.InaseM.TanjiJ.Pallidal and cerebellar inputs to thalamocortical neurons projecting to the supplementary motor area in Macaca fuscata: a triple-labeling light microscopic study.Anat Embiyol (Berl)1999199919
   PubMedGoogle Scholar
• IlinskyIA.YiH.Kultas-llinskyK.Mode of termination of pallidal afférents to the thalamus: a light and electron microscopic study with anterograde tracers and immunocytochemistry in Macaca mulatta.J Comp Neurol19973866016129378854
   PubMed Web of Science ®Google Scholar
• SakaiST.InaseM.TanjiJ.Comparison of cerebellothalamic and pallidothalamic projections in the monkey (Macaca fuscata): a double anterograde labeling study.J Comp Neurol199636821 5228
   Web of Science ®Google Scholar
• TokunoH.KimuraM.TanjiJ.Pallidal inputs to thalamocortical neurons projecting to the supplementary motor area: an anterograde and retrograde double labeling study in the macaque monkey.Exp Brain Res1992906356381385203
   PubMed Web of Science ®Google Scholar
• IlinskyIA.Kultas-llinskyK.Fine structure of the magnocellular subdivision of the ventral anterior thalamic nucleus (VAmc) of Macaca fuscata: I. Cell types and synaptology.J Comp Neurol19902944554782341621
   PubMed Web of Science ®Google Scholar
• Kultas-llinskyK.IlinskyIA.Fine structure of the magnocellular subdivision of the ventral anterior thalamic nucleus (VAmc) of Macaca fuscata: II. Organization of nigrothalamic afférents as revealed with EM autoradiography.J Comp Neurol19902944794892341622
   PubMed Web of Science ®Google Scholar
• SmithY.BevanMD.ShinkE.BolamJP.Microcircuitry of the direct and indirect pathways of the basal ganglia.Neuroscience1998863533879881853
   PubMed Web of Science ®Google Scholar
• BolamJP.HanleyJJ.BoothPA.BevanMD.Synaptic organisation of the basal ganglia.J Anat2000196(pt 4)52754210923985
   PubMed Web of Science ®Google Scholar
• ShinkE.BevanMD.BolamJP.SmithY.The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey.Neuroscience1996733353578783253
   PubMed Web of Science ®Google Scholar
• NambuA.TokunoH.HamadaI.et al.Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey.J Neurophysiol20008428930010899204
   PubMed Web of Science ®Google Scholar
• SatoF.ParentM.LevesqueM.ParentA.Axonal branching pattern of neurons of the subthalamic nucleus in primates.J Comp Neurol200042414215210888744
   PubMed Web of Science ®Google Scholar
• IlinskyIA.Kultas-llinskyK.Sagittal cytoarchitectonic maps of the Macaca fuscata thalamus with a revised nomenclature of the motor-related nuclei validated by observations on their connectivity.J Comp Neurol19872623313642821085
   PubMed Web of Science ®Google Scholar
• GerfenCR.KeefeKA.GaudaEB.D1 and D2 dopamine receptor function in the striatum: coactivation of D1 and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in Drcontaining neurons.J Neurosci199515816781768613751
   PubMed Web of Science ®Google Scholar
• Le MoineC.BlochB.D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of Di1and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.J Comp Neurol19953554184267636023
   PubMed Web of Science ®Google Scholar
• YungKK.SmithAD.LeveyAI.BolamJP.Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining.Eur J Neurosci199688618698743734
   PubMed Web of Science ®Google Scholar
• WongAC.ShetreatME.ClarkeJO.RayportS.D1 and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.Neuroscience19998922123310051231
   PubMed Web of Science ®Google Scholar
• YanZ.Flores-HernandezJ.SurmeierDJ.Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons.Neuroscience20011031017102411301208
   PubMed Web of Science ®Google Scholar
• PahapillPA.LozanoAM.The pedunculopontine nucleus and Parkinson's disease.Brain2000123(pt 9)1767178310960043
   PubMed Web of Science ®Google Scholar
• CalabresiP.CentonzeD.GubelliniP.PisaniA.BernardiG.Acetylcholinemediated modulation of striatal function.Trends Neurosci20002312012610675916
   PubMed Web of Science ®Google Scholar
• KawaguchiY.WilsonCJ.AugoodSJ.EmsonPC.Striatal interneurones: chemical, physiological and morphological characterization.Trends Neurosci1995185275358638293
   PubMed Web of Science ®Google Scholar
• KimuraM.AosakiT.HuY.IshidaA.WatanabeK.Activity of primate putamen neurons is selective to the mode of voluntary movement: visually guided, self-initiated or memory-guided.Exp Brain Res1992894734771644114
   PubMed Web of Science ®Google Scholar
• YamadaH.MatsumotoN.KimuraM.Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action.J Neurosci2004243500351015071097
   PubMed Web of Science ®Google Scholar
• KimuraM.The role of primate putamen neurons in the association of sensory stimuli with movement.Neurosci Res198634364433748474
   PubMedGoogle Scholar
• SchultzW.Getting formal with dopamine and reward.Neuron20023624126312383780
   PubMed Web of Science ®Google Scholar
• MorrisG.ArkadirD.NevetA.VaadiaE.BergmanH.Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons.Neuron20044313314315233923
   PubMed Web of Science ®Google Scholar
• AlbinRL.YoungAB.PenneyJB.The functional anatomy of basal ganglia disorders.Trends Neurosci1989123663752479133
   PubMed Web of Science ®Google Scholar
• GaoDM.BenazzouzA.PiallatB.et al.High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey.Neuroscience19998820121210051201
   PubMed Web of Science ®Google Scholar
• BoraudT.BezardE.BioulacB.GrossC.High frequency stimulation of the internal globus pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTPtreated monkey.Neurosci Lett199621517208880743
   PubMed Web of Science ®Google Scholar
• GuridiJ.HerreroMT.LuquinMR.et al.Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.Brain1996119(pt 5)171717278931592
   PubMed Web of Science ®Google Scholar
• JimenezF.VelascoF.VelascoM.et al.Subthalamic prelemniscal radiation stimulation for the treatment of Parkinson's disease: electrophysiological characterization of the area.Arch Med Res20003127028111036178
   PubMed Web of Science ®Google Scholar
• BrownRG.DowseyPL.BrownP.et al.Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.Ann Neurol19994547348810211472
   PubMed Web of Science ®Google Scholar
• ObesoJA.Rodriguez-OrozMC.RodriguezM.et al.Pathophysiologic basis of surgery for Parkinson's disease.Neurology200055(12 suppl 6)S7S1 211188978
   PubMed Web of Science ®Google Scholar
• WichmannT.DeLongMR.Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder.Ann N Y Acad Sci200399119921312846988
   PubMed Web of Science ®Google Scholar
• SamuelM.CaputoE.BrooksDJ.et al.A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.Brain1998121 (pt 1)59759549488
   PubMed Web of Science ®Google Scholar
• MinkJW.ThachWT.Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement.J Neurophysiol199165330351 2016644
   PubMed Web of Science ®Google Scholar
• SoaresJ.KliernMA.BetarbetR.GreenamyreJT.YamamotoB.WichmannT.Role of external pallidal segment in primate parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism and lesions of the external pallidal segment.J Neurosci2004246417642615269251
   PubMed Web of Science ®Google Scholar
• OhyeC.ShibazakiT.Lesioning the thalamus for dyskinesia.Stereotact Funct Neurosurg200177333912378054
   PubMed Web of Science ®Google Scholar
• TaskerRR.MunzM.JunnFS.et al.Deep brain stimulation and thalamotomy for tremor compared.Acta Neurochir Suppl (Wien)1997684953
   PubMedGoogle Scholar
• RazA.VaadiaE.BergmanH.Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism.J Neurosci2000208559857111069964
   PubMed Web of Science ®Google Scholar
• RazA.FeingoldA.ZelanskayaV.VaadiaE.BergmanH.Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates.J Neurophysiol199676208320888890317
   PubMed Web of Science ®Google Scholar
• NiniA.FeingoldA.SlovinH.BergmanH.Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phaselocked oscillations appear in the MPTP model of parkinsonism.J Neurophysiol199574180018058989416
   PubMed Web of Science ®Google Scholar
• GoldbergJA.RokniU.BoraudT.VaadiaE.BergmanH.Spike synchronization in the cortex-basal ganglia networks of parkinsonian primates reflects global dynamics of the local field potentials.J Neurosci2004246003601015229247
   PubMed Web of Science ®Google Scholar
• LiuX.Ford-DunnHL.HaywardGN.et al.The oscillatory activity in the Parkinsonian subthalamic nucleus investigated using the macro-electrodes for deep brain stimulation.Clin Neurophysiol20021131667167212417218
   PubMed Web of Science ®Google Scholar
• BevanMD.MagillPJ.TermanD.BolamJP.WilsonCJ.Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network.Trends Neurosci20022552553112220881
   PubMed Web of Science ®Google Scholar
• LevyR.AshbyP.HutchisonWD.LangAE.LozanoAM.DostrovskyJO.Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease.Brain2002125(pt 6)1196120912023310
   PubMed Web of Science ®Google Scholar
• BevanMD.MagillPJ.HallworthNE.BolamJP.WilsonCJ.Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABA-A IPSPs.J Neurophysiol2002871348136211877509
   PubMed Web of Science ®Google Scholar
• BevanMD.WilsonCJ.Mechanisms underlying spontaneous oscillation and rhythmic firing in rat subthalamic neurons.J Neurosci1999197617762810460267
   PubMed Web of Science ®Google Scholar
• BevanMD.WilsonCJ.BolamJP.MagillPJ.Equilibrium potential of GABA(A) current and implications for rebound burst firing in rat subthalamic neurons in vitro.J Neurophysiol2000833169317210805713
   PubMed Web of Science ®Google Scholar
• AminiB.ClarkJW Jr.CanavierCC.Calcium dynamics underlying pacemaker-like and burst firing oscillations in midbrain dopaminergic neurons: a computational study.J Neurophysiol1999822249226110561403
   PubMed Web of Science ®Google Scholar
• CheminJ.MonteilA.Perez-ReyesE.BourinetE.NargeotJ.LoryP.Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.J Physiol2002540(pt 1)31411927664
   PubMed Web of Science ®Google Scholar
• HughesSW.CopeDW.TothTl.WilliamsSR.CrunelliV.All thalamocortical neurones possess a T-type Ca2+ “window” current that enables the expression of bistability-mediated activities.J Physiol1999517(pt 3)80581510358120
   PubMed Web of Science ®Google Scholar
• HuguenardJR.PrinceDA.A novel T-type current underlies prolonged Ca(2+)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus.J Neurosci199212380438171403085
   PubMed Web of Science ®Google Scholar
• OguraM.KitaH.Dynorphin exerts both postsynaptic and presynaptic effects in the globus pallidus of the rat.J Neurophysiol2000833366337610848555
   PubMed Web of Science ®Google Scholar
• KitaH.KitaiST.Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation.Brain Res19915642963051810628
   PubMed Web of Science ®Google Scholar
• TermanD.RubinJE.YewAC.WilsonCJ.Activity patterns in a model for the subthalamopallidal network of the basal ganglia.J Neurosci2002222963297611923461
   PubMed Web of Science ®Google Scholar
• StanfordIM.CooperAJ.Presynaptic m and d opioid receptor modulation of GABAaIPSCs in the rat globus pallidus in vitro.J Neurosci1999194796480310366614
   PubMed Web of Science ®Google Scholar